Tenax Sales General And Administrative To Revenue from 2010 to 2024

TENX Stock  USD 5.94  0.29  5.13%   
Tenax Therapeutics Sales General And Administrative To Revenue yearly trend continues to be fairly stable with very little volatility. Sales General And Administrative To Revenue is likely to outpace its year average in 2024. During the period from 2010 to 2024, Tenax Therapeutics Sales General And Administrative To Revenue regression line of annual values had significance of  0.0003 and arithmetic mean of  99.37. View All Fundamentals
 
Sales General And Administrative To Revenue  
First Reported
2010-12-31
Previous Quarter
130.94
Current Value
137.49
Quarterly Volatility
68.1770106
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tenax Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tenax Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.2 K, Other Operating Expenses of 8.4 M or Research Development of 3.6 M, as well as many indicators such as Price To Sales Ratio of 141.3 K, Dividend Yield of 3.31 or PTB Ratio of 0.71. Tenax financial statements analysis is a perfect complement when working with Tenax Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Tenax Therapeutics Correlation against competitors.
For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.

Latest Tenax Therapeutics' Sales General And Administrative To Revenue Growth Pattern

Below is the plot of the Sales General And Administrative To Revenue of Tenax Therapeutics over the last few years. It is Tenax Therapeutics' Sales General And Administrative To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tenax Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Sales General And Administrative To Revenue10 Years Trend
Slightly volatile
   Sales General And Administrative To Revenue   
       Timeline  

Tenax Sales General And Administrative To Revenue Regression Statistics

Arithmetic Mean99.37
Coefficient Of Variation68.61
Mean Deviation58.49
Median145.49
Standard Deviation68.18
Sample Variance4,648
Range200
R-Value0.81
Mean Square Error1,752
R-Squared0.65
Significance0.0003
Slope12.29
Total Sum of Squares65,073

Tenax Sales General And Administrative To Revenue History

2024 137.49
2023 130.94
2015 145.49
2013 47.7
2012 2.98
2011 14.68
2010 -54.91

About Tenax Therapeutics Financial Statements

Tenax Therapeutics investors use historical fundamental indicators, such as Tenax Therapeutics' Sales General And Administrative To Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tenax Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Sales General And Administrative To Revenue 130.94  137.49 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tenax Stock Analysis

When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.